$VKTX SEC Filings

Filed On	Filing
28 Sep 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Reconciliation and tie between Trust Indenture Act of 1939 and
25 Sep 2026	424B5
25 Sep 2026	424B5
24 Sep 2026	FREE WRITING PROSPECTUS
24 Sep 2026	APPLICATION FOR DESIGNATION OF A NEW TRUSTEE
23 Sep 2026	424B5
23 Sep 2026	424B5
22 Sep 2026	8-K: Other Events Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens
07 Aug 2026	Form 4: Kelly-Gemmell Dorothy Elizabeth, Director Received 6,333 shares as a grant or award · Granted 40,800 Stock Option (Right to Buy)
07 Aug 2026	Form 3: Kelly-Gemmell Dorothy Elizabeth, Director No securities owned
30 Jul 2026	S-3ASR
29 Jul 2026	Form 4: Lian Brian, Director Received 221,667 shares as a grant or award · Sold 148,517 shares ($4.95M)
29 Jul 2026	Form 4: Zante Greg, Chief Financial Officer Received 31,667 shares as a grant or award · Sold 21,217 shares ($710K)
29 Jul 2026	Form 4: Mancini Marianna, Chief Operating Officer Received 31,667 shares as a grant or award · Sold 18,217 shares ($610K)
29 Jul 2026	10-Q
29 Jul 2026	144
29 Jul 2026	144
29 Jul 2026	144
29 Jul 2026	8-K: Results of Operations and Financial Condition
03 Jun 2026	Form 4: Chen Hubert C, Chief Medical Officer Granted 190,000 Stock Option (Right to Buy)

Comments